Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. | Endocrinology;142(8): 3616-24, 2001 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.

Stefferl, A; Storch, M K; Linington, C; Stadelmann, C; Lassmann, H; Pohl, T; Holsboer, F; Tilders, F J; Reul, J M.

Affiliation

Stefferl A; Max Planck Institute of Psychiatry, Section of Neuropsychopharmacology, D-80804 Munich, Germany.

Endocrinology ; 142(8): 3616-24, 2001 Aug.

Article in En | MEDLINE | ID: mdl-11459810

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Corticosterone / Encephalomyelitis, Autoimmune, Experimental Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Endocrinology Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Corticosterone / Encephalomyelitis, Autoimmune, Experimental Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Endocrinology Year: 2001 Document type: Article Affiliation country: Country of publication: